DEEOIC To Require Prior Authorization for Compounded Drugs

Division of Energy Employees Occupational Illness Compensation (DEEOIC)

Beginning on November 4, 2024, the Division of Energy Employees Occupational Illness Compensation (DEEOIC) will require prior authorization for compounded drugs.  

Requests for prior authorization must be submitted on Form OWCP-26 and include an opinion from a qualified physician that provides a compelling, well-rationalized justification for the use of a compounded drug to treat an illness accepted under the Energy Employees Occupational Illness Compensation Program Act (EEOICPA). A completed Form OWCP-26 does not guarantee authorization by DEEOIC.  If a claimant does not have an approved authorization for a compounded drug, the dispensing pharmacy will receive a notification that the compounded drug will be denied, and that prior authorization is required.  

Physicians, pharmacies, and claimants may call OWCP’s pharmacy bill processor, Conduent, at 1-866-664-5581 for compounded drug processing questions.